Answers are grounded in this paper and cite their sources.
Explores genetic testing in diagnosing pyruvate kinase deficiency in infants, highlighting improved diagnostic accuracy.
Diagnosing neonatal pyruvate kinase (PK) deficiency is challenging, especially when early transfusions render conventional testing inconclusive. Genetic testing, however, is not influenced by transfusions and can provide, in most cases, a definitive diagnosis. We report two unrelated infants with symptomatic PK deficiency, both compound heterozygous for PKLR mutations, including two undescribed missense variants (c.865C>T; p.(Arg289Trp) and c.1016A>G; p.(Asp339Gly)). These cases underscore the critical role of molecular testing -particularly hereditary hemolytic anemia next-generation sequencing (NGS) panels-in confirming the diagnosis when enzymatic assays are unfeasible, further shortening time to diagnosis in congenital hemolytic anemias.
No takes yet. Share an insight, caveat, or question.
Sakalian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: